Cell Biotech Co., Ltd. (KOSDAQ:049960)
South Korea flag South Korea · Delayed Price · Currency is KRW
14,160
-240 (-1.67%)
At close: Apr 2, 2026

Cell Biotech Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
96,91089,72497,66276,78986,918133,300
Market Cap Growth
5.91%-8.13%27.18%-11.65%-34.80%-19.84%
Enterprise Value
4,2731,34319,19010,61222,95970,193
Last Close Price
14160.0013110.0013643.6610388.7711289.5916183.18
PE Ratio
9.578.866.4612.1810.5012.84
Forward PE
-8.168.168.168.168.16
PS Ratio
1.821.691.961.431.722.84
PB Ratio
0.740.680.790.690.801.25
P/TBV Ratio
0.740.690.800.700.821.27
P/FCF Ratio
12.1111.215.3812.268.329.49
P/OCF Ratio
8.728.085.079.826.788.95
EV/Sales Ratio
0.080.030.380.200.451.50
EV/EBITDA Ratio
0.370.121.801.742.376.36
EV/EBIT Ratio
0.540.172.824.833.799.67
EV/FCF Ratio
0.530.171.061.692.205.00
Debt / Equity Ratio
0.000.000.010.010.010.01
Debt / EBITDA Ratio
0.040.040.100.250.100.07
Debt / FCF Ratio
0.050.050.060.250.090.06
Net Debt / Equity Ratio
-0.70-0.70-0.70-0.61-0.60-0.53
Net Debt / EBITDA Ratio
-8.04-8.04-8.10-11.28-6.65-5.16
Net Debt / FCF Ratio
-11.57-11.57-4.76-10.98-6.17-4.06
Asset Turnover
0.400.400.400.460.440.43
Inventory Turnover
3.353.353.393.683.343.21
Quick Ratio
20.1920.1915.7115.749.5410.89
Current Ratio
21.3421.3416.5716.9910.2411.71
Return on Equity (ROE)
7.92%7.92%12.82%5.73%7.71%10.05%
Return on Assets (ROA)
3.71%3.71%3.43%1.18%3.31%4.16%
Return on Invested Capital (ROIC)
18.32%18.56%16.29%4.63%10.55%12.97%
Return on Capital Employed (ROCE)
6.00%6.00%5.50%1.90%5.60%6.80%
Earnings Yield
10.45%11.29%15.49%8.21%9.53%7.79%
FCF Yield
8.26%8.92%18.57%8.16%12.02%10.54%
Dividend Yield
3.13%--4.33%3.99%2.78%
Payout Ratio
30.42%30.42%20.36%48.86%38.43%30.65%
Buyback Yield / Dilution
-0.02%-0.02%-0.01%0.73%2.50%0.32%
Total Shareholder Return
3.20%-0.02%-0.01%5.07%6.49%3.10%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.